Paper - WANFANG MED ONLINE

You Position: Home > Paper

Construction of the alpha-fetoprotein enhancer controlled gene therapy vector specific for hepatocellular carcinoma and identification of its activity

( views:264, downloads:4 )

Author:: No author available

Journal Title:: WORLD CHINESE JOURNAL OF DIGESTOLOGY

Issue:: 33

DOI:: 10.3969/j.issn.1009-3079.2007.33.004

Key Word:: 甲胎蛋白;启动子;增强子;克隆;聚合酶链式反应;载体;肝癌

Abstract：目的:构建新型AFP顺式作用元件调控的基因表达载体,检测该调控元件的特异性和活性表达.方法:设计含有特定酶切位点的引物,采用PCR法从HepG2细胞中克隆AFP启动子及增强子基因亚区片段.启动子与增强子长、短片段分别与含有报告基因荧光素酶基因的载体pGL-3的多克隆位点连接,构建不同长度hAFP增强子调控的肝癌特异性Luciferase表达载体APSE-Luc/APLE-Luc.经测序,PCR及酶切鉴定各重组体.用脂质体法将表达载体转染表达或不表达AFP的肿瘤细胞系进行荧光强度及特异性表达测定.结果:成功地将AFP基因启动子、增强子克隆到报告基因载体pGL-3的多克隆位点,构建成为不同长度hAFP增强子调控的肝癌特异性Luciferase表达载体APSE-Luc/APLE-Luc,酶切鉴定和DNA序列分析无误.转染APLE-Luc质粒的细胞中Luciferase表达量明显高于转染APSE-Luc质粒的细胞,其在HepG2细胞中的表达明显高于SMMC7721细胞及Hela细胞.结论:成功构建AFP启动子与增强子联合调控载体APSE-Luc/APLE-Luc.AFP增强子能够特异性地增强目的基因在AFP阳性细胞中表达,并且不同的亚区活性不同,长片段的活性明显高于短片段.

Reference

[1]Meng-Sen Li,Ping-Feng Li,QIAN Chen,etc.Alpha-fetoprotein stimulated the expression of some oncogenes in human hepatocellular carcinoma Bel 7402 cells[J].2004,(6).
[2]Shao-Ying Lu,Yan-Fang Sui,Zeng-Shan Li,etc.Construction of a regulable gene therapy vector targeting for hepatocellular carcinoma[J].2003,(4).
[3]黄蕤,匡安仁,余海放,等.携带人NIS基因的重组腺病毒的构建[J].2005,(4).
[4]Dénes G(o)r(o)g,János Reg(o)ly-Mérei,Sándor Paku,etc.Alpha-fetoprotein expression is a potential prognostic marker in hepatocellular carcinoma[J].2005,(32).
[5]Niitsu Y,Sagawa T,Yamashita T,etc.E1B-55K-deleted adenovirus expressing E1A-13S by AFP-enhancer/promoter is capable of highly specific replication in AFP-producing hepatocellular carcinoma and eradication of established tumor.[J].2002,5(5).
[6]G U, Dachs,G J, Dougherty,I J, Stratford,etc.Targeting gene therapy to cancer: a review.[J].1997,9.
[7]Fumihiko Kanai.Transcriptional Targeted Gene Therapy for Hepatocellular Carcinoma by Adenovirus Vector[J].2001,18(3).
[8]Brechot C,Dubois S,Sa Cunha A,etc.Inhibition of rat hepatocellular carcinoma tumor growth after multiple infusions of recombinant Ad.AFPtk followed by ganciclovir treatment.[J].2002,37(2).
[9]Makuuchi M,Kaminishi M,Muller R,etc.An advanced strategy of enhanced specific gene expression for hepatocellular carcinoma.[J].2003,22(5).
[10]K, Watanabe,A, Saito,T, Tamaoki.Cell-specific enhancer activity in a far upstream region of the human alpha-fetoprotein gene.[J].1987,262.
[11]Takayama E,Hiroi S,Tsutsui K,etc.Selective inhibition of hepatoma cells using diphtheria toxin A under the control of the promoter/enhancer region of the human alpha-fetoprotein gene.[J].2000,91(3).
[12]Ebara M,Wada A,Kadomatsu K,etc.A promoter region of the midkine gene that is frequently expressed in human hepatocellular carcinoma can activate a suicide gene as effectively as the alpha-fetoprotein promoter.[J].2003,89(6).
[13]A, Ido,K, Nakata,Y, Kato,etc.Gene therapy for hepatoma cells using a retrovirus vector carrying herpes simplex virus thymidine kinase gene under the control of human alpha-fetoprotein gene promoter.[J].1995,55.
[14]Brown JM,Shibata T,Giaccia AJ.Development of a hypoxia-responsive vector for tumor-specific gene therapy.[J].2000,7(6).
[15]Huang XQ,Gu W,Zhu DZ,etc.Inhibitory effect of recombinant adenovirus carrying melittin gene on hepatocellular carcinoma.[J].2005,16(1).
[16]Hua Su,Judy C. Chang,Shan Mei Xu,etc.Selective Killing of AFP-Positive Hepatocellular Carcinoma Cells by Adeno-Associated Virus Transfer of the Herpes Simplex Virus Thymidine Kinase Gene[J].1996,7(4).
[17]Guo J,Meng X,Zhao Y,etc.A tumor-specific conditionally replicative adenovirus vector expressing TRAIL for gene therapy of hepatocellular carcinoma.[J].2006,13(2).
[18]S, Kaneko,P, Hallenbeck,T, Kotani,etc.Adenovirus-mediated gene therapy of hepatocellular carcinoma using cancer-specific gene expression.[J].1995,55.
[19]B, Levin,C, Amos.Therapy of unresectable hepatocellular carcinoma.[J].1995,332(19).